These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24391884)

  • 1. Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney.
    Sun YB; Qu X; Li X; Nikolic-Paterson DJ; Li J
    PLoS One; 2013; 8(12):e84063. PubMed ID: 24391884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-10 Family Promotes Renal Fibrosis through the VASH-1/Smad3 Pathway.
    Shuai Y; Xu N; Zhao C; Yang F; Ning Z; Li G
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation.
    Ai J; Nie J; He J; Guo Q; Li M; Lei Y; Liu Y; Zhou Z; Zhu F; Liang M; Cheng Y; Hou FF
    J Am Soc Nephrol; 2015 Aug; 26(8):1827-38. PubMed ID: 25392233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.
    Meng XM; Zhang Y; Huang XR; Ren GL; Li J; Lan HY
    Oncotarget; 2015 Nov; 6(35):36984-97. PubMed ID: 26474462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis.
    Song A; Yan R; Xiong W; Xiang H; Huang J; Jiang A; Zhang C
    Transl Res; 2024 Sep; 271():13-25. PubMed ID: 38679230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Cα drives fibroblast activation and kidney fibrosis by stimulating autophagic flux.
    Xue X; Ren J; Sun X; Gui Y; Feng Y; Shu B; Wei W; Lu Q; Liang Y; He W; Yang J; Dai C
    J Biol Chem; 2018 Jul; 293(28):11119-11130. PubMed ID: 29794026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taz/Tead1 Promotes Alternative Macrophage Activation and Kidney Fibrosis via Transcriptional Upregulation of Smad3.
    Ren Y; Zhou L; Li X; Zhu X; Zhang Z; Sun X; Xue X; Dai C
    J Immunol Res; 2024; 2024():9512251. PubMed ID: 39108258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TL1A Promotes Fibrogenesis in Colonic Fibroblasts via the TGF-β1/Smad3 Signaling Pathway.
    Song J; Sun DL; Li CY; Luo YX; Liu Q; Yao Y; Zhang H; Yang TT; Song M; Bai XL; Zhang XL
    Curr Med Sci; 2024 Jun; 44(3):519-528. PubMed ID: 38842774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.
    Wang M; Chen DQ; Chen L; Cao G; Zhao H; Liu D; Vaziri ND; Guo Y; Zhao YY
    Br J Pharmacol; 2018 Jul; 175(13):2689-2708. PubMed ID: 29679507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration.
    Azouz AA; Tohamy MA; Ali FEM; Mahmoud HM
    Life Sci; 2024 Oct; 355():122995. PubMed ID: 39159720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis.
    Poosti F; Bansal R; Yazdani S; Prakash J; Post E; Klok P; van den Born J; de Borst MH; van Goor H; Poelstra K; Hillebrands JL
    FASEB J; 2015 Mar; 29(3):1029-42. PubMed ID: 25466892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure.
    Su CT; Jao TM; Urban Z; Huang YJ; See DHW; Tsai YC; Lin WC; Huang JW
    Cell Death Dis; 2021 Oct; 12(10):943. PubMed ID: 34645813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bulk and single-cell transcriptome profiling identify potential cellular targets of the long noncoding RNA Gas5 in renal fibrosis.
    Zhang X; Hu S; Xiang X; Li Z; Chen Z; Xia C; He Q; Jin J; Chen H
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167206. PubMed ID: 38718848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD9 targets
    Samokhin AO; Stephens T; Wertheim BM; Wang RS; Vargas SO; Yung LM; Cao M; Brown M; Arons E; Dieffenbach PB; Fewell JG; Matar M; Bowman FP; Haley KJ; Alba GA; Marino SM; Kumar R; Rosas IO; Waxman AB; Oldham WM; Khanna D; Graham BB; Seo S; Gladyshev VN; Yu PB; Fredenburgh LE; Loscalzo J; Leopold JA; Maron BA
    Sci Transl Med; 2018 Jun; 10(445):. PubMed ID: 29899023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The secreted micropeptide C4orf48 enhances renal fibrosis via an RNA-binding mechanism.
    Yang J; Zhuang H; Li J; Nunez-Nescolarde AB; Luo N; Chen H; Li A; Qu X; Wang Q; Fan J; Bai X; Ye Z; Gu B; Meng Y; Zhang X; Wu D; Sia Y; Jiang X; Chen W; Combes AN; Nikolic-Paterson DJ; Yu X
    J Clin Invest; 2024 Apr; 134(10):. PubMed ID: 38625739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 Receptor Signaling Negatively Regulates the Development of Tubulointerstitial Fibrosis in the Kidney.
    Ramani K; Tan RJ; Zhou D; Coleman BM; Jawale CV; Liu Y; Biswas PS
    Mediators Inflamm; 2018; 2018():5103672. PubMed ID: 30405320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.
    Yuen DA; Connelly KA; Advani A; Liao C; Kuliszewski MA; Trogadis J; Thai K; Advani SL; Zhang Y; Kelly DJ; Leong-Poi H; Keating A; Marsden PA; Stewart DJ; Gilbert RE
    PLoS One; 2010 Mar; 5(3):e9543. PubMed ID: 20209052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction: GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF- β -Induced Smad3 Phosphorylation.
    J Am Soc Nephrol; 2024 Apr; 35(4):517. PubMed ID: 38414138
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic targets for treating fibrotic kidney diseases.
    Lee SY; Kim SI; Choi ME
    Transl Res; 2015 Apr; 165(4):512-30. PubMed ID: 25176603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for specialized pro-resolving mediators in pulmonary fibrosis?
    Thatcher TH; Freeberg MAT; Myo YPA; Sime PJ
    Pharmacol Ther; 2023 Jul; 247():108460. PubMed ID: 37244406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.